00:00Tell us a little bit more put it into context in terms of just how much more IPO activity we're going to see. Well we're seeing three deals pricing this week. We see the biggest deal globally expected to price next week in Medline. So you're seeing activity finally pick up here in December. Expectations are that we should be off to a strong start in January. Yes you'll have your typical biotech leading the way out. But bankers that we're talking to are pointing towards the likes of equipment share which flip public formally today which could raise up to a billion dollars we had reported earlier this year.
00:29As well as a number of other companies think about in the crypto space you've got BitGo on file publicly. Kraken is one we're all keeping a close eye on potentially for the end of first quarter. So it does seem like we're seeing a roster actually fill out which is different than what we saw last year at this time when bankers were really kind of their typical optimistic selves as opposed to being able to point to deals that either were stuck in the hopper due to the government shutdown or that they're finally seeing some of those mandates come to light. You named a bunch of companies. I didn't hear you say anything about SpaceX. Did not say anything.
00:59about SpaceX potentially though next year late next year is what we've been reporting. So that'll be one to keep an eye on. It's been interesting just talking to bankers about kind of this cadence of news that we've heard from a SpaceX from an open AI from an anthropic that there actually does seem to be some type of appetite to going public late in 2026 maybe in 2027. Again that's a complete about face from what we had been hearing for a number of months from those companies.
01:23So 2025 is going to look good partly because 2024 was not necessarily spectacular. But do we get back to the levels that we saw you know around 2021 2022.
01:32I don't think we ever will. And I think that's really what analysts and bankers are saying. When you look at the data this year we're going to come in above 40 billion dollars which is closer to that pre pandemic decade norm. But as you can see on that chart 131 billion 194 billion.
01:45these are huge numbers that even the most optimistic banker will say were anomalies that we saw pretty much every company that could go public jamming to get out the door.
Be the first to comment